Skip to main content
Clinical Trials/JPRN-UMIN000019309
JPRN-UMIN000019309Completed未知

Hyperemic Efficacy of nicorandil for fractional flow reserve measurement in patients with stable coronary artery disease - Hyperemic efficacy of nicorandil

Chiba University Graduate School of Medicine0 sites50 target enrollmentStarted: October 15, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 89years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Acute coronary syndrome within the previous 1 week,vessels with prior myocardial infarction, allergy to adenosine of nicorandil,asthma or chronic obstructive pulmonary disease on medical treatment, second or third degree atrioventricular block, severe valvular heart disease, acute decompensated heart failure, reduced left ventricular function (ejection fraction less than or equal to 30%), severe liver dysfunction, severe renal insufficiency, angle-closure glaucoma, patients who are taking phosphodiesterase type 5 (PDE5) Inhibitors, pregnancy, patients who were not suitable for enrollment

Investigators

Sponsor
Chiba University Graduate School of Medicine

Similar Trials